(Q46784053)

25 December 2017

title

Familial Parkinson mutant alpha-synuclein causes dopamine neuron dysfunction in transgenic Caenorhabditis elegans (English)

1 reference

25 December 2017

main subject

Caenorhabditis elegans

0 references

0 references

1 reference

1 reference

7

Shohei Mitani

1 reference

25 December 2017

Keiko Gengyo-Ando

3

object named as

Keiko Gengyo-Ando

1 reference

25 December 2017

author name string

Tomoki Kuwahara

1

1 reference

25 December 2017

Akihiko Koyama

2

1 reference

25 December 2017

Mayumi Masuda

4

1 reference

25 December 2017

Hisatomo Kowa

5

1 reference

25 December 2017

Makoto Tsunoda

6

1 reference

25 December 2017

Takeshi Iwatsubo

8

1 reference

25 December 2017

language of work or name

English

0 references

publication date

31 October 2005

1 reference

25 December 2017

Journal of Biological Chemistry

published in

1 reference

25 December 2017

volume

281

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

page(s)

334-340

1 reference

25 December 2017

Molecular Pathways of Neurodegeneration in Parkinson's Disease

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504860200

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504860200

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504860200

The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504860200

alpha-Synuclein locus triplication causes Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504860200

Alpha-synuclein locus duplication as a cause of familial Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504860200

Alpha-synuclein in Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504860200

Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504860200

Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504860200

Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504860200

The E46K mutation in alpha-synuclein increases amyloid fibril formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504860200

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504860200

Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504860200

Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504860200

Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504860200

Motor dysfunction and gliosis with preserved dopaminergic markers in human alpha-synuclein A30P transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504860200

A Drosophila model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504860200

Pharmacological prevention of Parkinson disease in Drosophila.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504860200

Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504860200

Yeast cells provide insight into alpha-synuclein biology and pathobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504860200

C. elegans locomotory rate is modulated by the environment through a dopaminergic pathway and by experience through a serotonergic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504860200

Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504860200

Dopaminergic neurons in the nematodeCaenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504860200

Mostly separate distributions of CLAC- versus Abeta40- or thioflavin S-reactivities in senile plaques reveal two distinct subpopulations of beta-amyloid deposits

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504860200

Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504860200

Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504860200

Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504860200

Mechanisms of Suppression of {alpha}-Synuclein Neurotoxicity by Geldanamycin in Drosophila.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504860200

Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504860200

Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504860200

Alpha-synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504860200

21 January 2018

Identifiers

DOI

10.1074/JBC.M504860200

1 reference

25 December 2017

1 reference

25 December 2017